Table 1 Study cohort composition. Patient numerosity for each covariate under study at enrollment.
From: Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +
Covariate | Levels | Gender | # | Age | ||||
|---|---|---|---|---|---|---|---|---|
20–39 | 40–59 | 60–79 | 80–99 | Mean ± SD | ||||
Main outcome | Asymptomatic: 36 | M F | 22 14 | 4 6 | 8 3 | 7 3 | 3 2 | 56 ± 20 50 ± 22 |
Symptomatic:156 | M F | 105 51 | 20 9 | 42 15 | 29 17 | 14 10 | 56 ± 18 60 ± 19 | |
Total: 192 | M F | 127 65 | 24 15 | 50 18 | 36 20 | 17 12 | 56 ± 18 58 ± 20 | |
Pneumonia | Mild: 89 | M F | 65 24 | 15 5 | 33 7 | 12 7 | 5 5 | 52 ± 17 59 ± 21 |
Moderate: 50 | M F | 25 25 | 4 4 | 6 8 | 8 9 | 7 4 | 63 ± 18 60 ± 18 | |
Severe: 17 | M F | 15 2 | 1 0 | 3 0 | 9 1 | 2 1 | 64 ± 17 80 ± 14 | |
Total: 156 | M F | 105 51 | 20 9 | 42 15 | 29 17 | 14 10 | 56 ± 18 60 ± 19 | |
Supplemental O2 | Low/High-flow O2: 72 (intubated: 18) | M F | 42 (16) 30 (2) | 3 (1) 4 (0) | 11 (4) 8 (1) | 20 (9) 11 (1) | 8 (1) 7 (0) | 64 ± 16 (62 ± 17) 63 ± 18 (58 ± 24) |
